Navigation Links
Researchers Make Insulin-Producing Cells From Adult Skin Cells
Date:8/31/2009

May provide research model, possible treatment for type 1 diabetes in future,,,,

MONDAY, Aug. 31 (HealthDay News) -- Using skin cells from people with type 1 diabetes, researchers were able to produce cells that made insulin in response to changing blood sugar levels, though not as efficiently as normal insulin-producing cells do.

The major immediate implication from this experiment is that scientists now have a preliminary lab model of human type 1 diabetes cells, and the hope is that an animal model of the disease could be developed from this research. Down the road, this finding could lead to a way to replace the islet cells that were destroyed when the disease first developed.

"This is a big deal," said Susan Solomon, CEO of the New York Stem Cell Foundation, which provided some of the funding for the study. "Tackling the basic biology of type 1 diabetes, which is a very complex disease, is a critical step. With these cells, we can see in a dish what's happening to the immune system, and if you don't understand the immune response, you get nowhere with type 1 diabetes."

"This is very preliminary data, but now we could potentially look at the interaction between immune system cells and insulin-producing cells to find the root cause or trigger, which we think might vary from patient to patient," explained Meri Firpo, an assistant professor at the Stem Cell Institute at the University of Minnesota.

Results of the study will be published in this week's online edition of the Proceedings of the National Academy of Sciences.

Type 1 diabetes is believed to be an autoimmune disease that destroys the insulin-producing islet (beta) cells in the pancreas. Because the body no longer produces its own insulin, people with type 1 diabetes must replace that lost insulin through injections or an insulin pump. Researchers suspect that people who develop the disease have a genetic susceptibility to the disease and that an environmental factor, such as a virus, somehow triggers the disease.

In the current study, researchers from the Howard Hughes Medical Institute at the Harvard Stem Cell Institute and the Naomi Berrie Diabetes Center at Columbia University, obtained skin samples from two white males who had type 1 diabetes. One was diagnosed at 3 years of age, while the other was first diagnosed when he was 21.

Normal skin cells are already specialized cells. Their job is to protect the body with a covering of skin, explained Firpo. To transform these cells into embryonic-like stem cells, essentially getting them back to the beginning when they weren't already specialized, researcher Doug Melton and his colleagues used three inserted genes to reprogram the cells, creating what's known as an induced pluripotent stem cell (iPS). In this case, the cells were then turned into insulin-producing cells.

Along with helping to provide a model of type 1 diabetes, this technology might also one day be used to create islet cells for transplant from a person's own skin cells. That way, there would be no need for immunosuppressive medications.

However, because the current technique uses genetic manipulation to change the cell, Firpo said long-term safety issues would have to be addressed. Mouse cells that have been similarly manipulated have developed benign tumors, she said. So, using such cells for transplant is definitely not "a near-term thing," she stressed.

The practical implications from this study "are primarily research-related," said Julia Greenstein, director of beta cell replacement for the Juvenile Diabetes Research Foundation (JDRF) in New York City.

She said that this study helps further at least two areas of research that JDRF is focusing on: developing a self-source for islet-cell transplants and blocking the immune response. Another area of research that JDRF is actively pursuing is the possible encapsulation of islet cells before transplantation so that they could hide from the immune system.

"Our hope is that understanding all of these things will come together -- that once we've figured out how to make the cell source that we'll also have figured out how to block the immune response, but there's a lot of basic science one has to do to get there," said Greenstein.

The good news, she added, is that "there's an incredible amount of exciting research that has the capacity to impact the disease in the long-term going on."

More information

Learn more about type 1 diabetes from the Juvenile Diabetes Research Foundation.



SOURCES: Julia Greenstein, Ph.D., director, beta cell replacement, Juvenile Diabetes Research Foundation, New York City; Susan Solomon, CEO, New York Stem Cell Foundation, New York City; Meri Firpo, Ph.D., assistant professor, The Stem Cell Institute, University of Minnesota, Minneapolis; Aug. 31-Sept. 4, 2009 Proceedings of the National Academy of Sciences, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers Make Insulin-Producing Cells From Adult Skin Cells
(Date:10/13/2017)... ... October 13, 2017 , ... ... PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor ... prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. The ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ANGELES (PRWEB) , ... October 12, 2017 , ... ... Parsa Mohebi Hair Restoration, has recently contributed a medical article to the newly ... on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: